Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +5.99% | 0.00% | -18.06% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 185M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 17M | EV / Sales 2024 * | 1.78 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.56 x |
P/E ratio 2024 * |
708
x | P/E ratio 2025 * |
11.4
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
Latest transcript on Alimera Sciences, Inc.
1 day | +5.99% | ||
Current month | -9.23% | ||
1 month | -11.06% | ||
3 months | -9.46% | ||
6 months | +16.07% | ||
Current year | -18.06% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 3.54 | +5.99% | 25,959 |
24-04-19 | 3.34 | -2.91% | 48,043 |
24-04-18 | 3.44 | -3.10% | 56,785 |
24-04-17 | 3.55 | -0.84% | 4,391 |
24-04-16 | 3.58 | +1.13% | 49,289 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.06% | 185M | |
-2.67% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+54.63% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-1.57% | 8.18B |
- Stock Market
- Equities
- ALIM Stock